Syringe System Quality Control for Audit Readiness
Bettine Boltres

Bettine Boltres

PhD., Director, Scientific Affairs

九月 30, 2026

Quality - The Person Who Has to Prove It Works, Every Time

You’re the person who gets asked the same question in a hundred different ways:
“Can we stand behind this?”
Not just today when the batch is on time and the audit calendar is quiet. But later: when a deviation trend shows up, when a supplier changes a process, when a complaint lands, when a regulator asks you to demonstrate control, not just claim it.
Quality is the function that turns good intentions into evidence. And what makes your role uniquely demanding is that you’re responsible for outcomes you don’t fully control, because quality is only as strong as the system of suppliers, interfaces, and handoffs behind it.

Your goals and objectives (what “success” means in Quality)

You’re not optimizing for speed alone, or cost alone, or convenience alone. Your job is to ensure that the entire product and its delivery system are consistently safe, compliant, and defendable.

Your priorities typically look like this:

  • Build and maintain a state of control: You want processes and product performance that are stable, predictable, and measurable, so “surprises” become rare events, not recurring patterns.
  • Protect patient safety: Everything leads back to this. If the delivery system compromises dose delivery, sterility assurance, or usability at scale, it’s a quality problem, no matter where it started.
  • Audit readiness at all times: You need documentation, traceability, and rationale that hold up under pressure - internal audits, partner audits, customer audits, and regulatory inspections.
  • Robust deviation and CAPA management: When issues happen (because they always do), you need clean root-cause analysis, clear ownership, and CAPAs that actually prevent recurrence.
  • Supplier quality confidence: You need suppliers who operate with mature quality systems, disciplined change control, and reliable documentation, because supplier issues become your issues.
  • Frictionless cross-functional collaboration: Quality sits in the middle of Manufacturing, Regulatory, CMC, Procurement, and suppliers, often translating between “we need it now” and “we need it controlled.”

In other words: you’re trying to enable progress without gambling.

Your challenges (what makes it hard to stay in control)

Quality work becomes exponentially harder when the syringe system is fragmented across multiple suppliers and interfaces. Because then you’re not managing one system - you’re managing a network of dependencies.

Common pain points you deal with:

  • Interface risk across components: When all the components are sourced separately, the system performance depends on interactions that aren’t “owned” end-to-end by any single party.
  • Ambiguity in accountability: When something goes wrong (a trend in defects, a complaint, a process drift), too often the first response is: “It’s not our component.” You end up arbitrating responsibility instead of driving resolution.
  • Change control complexity: Multiple suppliers mean multiple change control systems, timelines, justifications, and documentation formats - each change creating potential ripple effects in validation, stability, or performance.
  • Documentation burden and mismatch: Different supplier standards, different evidence packages, different data depth. You spend time bridging gaps rather than building a clean, coherent quality narrative.
  • Audit overload: Each supplier adds audits, follow-ups, corrective actions, and ongoing monitoring. This isn’t just administrative, each additional interface is another place risk can enter unnoticed.
  • Faster timelines, same expectations: You’re expected to accelerate development and supply, while still ensuring every decision is compliant, defendable, and controlled.

And the truth is: even strong internal quality systems can’t fully compensate for external complexity that is structurally built into the supply chain.

Your fears (the scenarios you’re actively preventing)

Quality professionals don’t “worry” in a vague way. You run scenarios, because you’ve seen how quickly minor signals become major problems.

The fears you’re managing are very real:

  • A compliance finding you could have prevented: An inspection or partner audit uncovers missing traceability, weak change control linkage, or unclear component responsibility, and suddenly you’re in escalation mode.
  • A deviation trend that points to systemic weakness: Not a one-off, but a pattern. And patterns often trace back to interfaces, supplier drift, or unclear specifications.
  • A complaint that becomes a credibility issue: Especially when it ties to functional performance - dose delivery, breakage, particles, or perceived device unreliability, because then it’s no longer “just quality”; it’s market confidence.
  • CAPAs that don’t stick: When root cause is split across suppliers, CAPAs risk becoming partial fixes. Partial fixes create recurrence. Recurrence destroys trust.
  • Ultimately: patient impact and recall risk: The highest-stakes scenario where quality escape affects patients or forces market action, with downstream consequences for the product and the company.

You’re constantly balancing: “move forward” versus “prove control.” And the more fragmented the syringe system, the more that balance tilts toward firefighting.

How we solve it: one accountable syringe system, fewer weak links, cleaner quality ownership

This is where West Synchrony™ S1 PFS System changes the quality equation.

We provide the complete syringe system from one accountable source.For you, that translates into very practical quality advantages:

  • Clear end-to-end accountability: When a system is owned as a system, you remove the “supplier triangle” problem. Investigation pathways become faster, cleaner, and more conclusive, because responsibility is not fragmented.
  • Simplified change control impact assessment: One supplier’s integrated view of the system reduces the risk of hidden interactions and helps you evaluate changes with greater confidence and better documentation alignment.
  • More coherent documentation packages: Instead of stitching together disparate evidence sets, you can anchor your quality narrative in a unified system-level approach, supporting audits, inspections, and internal governance.
  • Reduced supplier quality overhead: Fewer supplier interfaces typically mean fewer audits, fewer recurring follow-ups, and less time spent coordinating corrective actions across organizations.
  • A stronger “state of control” story: When the syringe is treated as a complete system rather than a collection of parts, it becomes easier to demonstrate process consistency, traceability, and risk management across the lifecycle.

And perhaps most importantly:

You get to spend less time defending the basics and more time strengthening the system proactively. Because quality isn’t about catching problems. It’s about designing a supply chain and a device system where problems are structurally less likely to happen in the first place.